The groundbreaking treatment of the medication represents a exciting development in the management of the condition. Distinct from existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide240760.livebloggs.com/48873037/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment